Perlara PBC, based in South San Francisco, CA, is a public benefit corporation that is dedicated to developing cures for rare diseases and understanding the connections between genes and common ailments. Through their innovative PerlQuests, Perlara scientists collaborate with motivated families, patient organizations, and researchers to identify potential treatments and map gene connections across diseases. Their groundbreaking work includes the identification of tool compounds, repurposable drugs, and novel chemotypes that rescue disease models in worms, flies, yeast, and patient fibroblasts.
With a focus on diseases such as NGLY1, NPA, PMM2-CDG, MSD, GNAO1, Pancreatitis, GSD III, MPSIIIA, MPSIIIB, Leigh Syndrome, APOL1 kidney disease, and more, Perlara's expertise and collaborative efforts offer hope for new insights and improved lives for patients. Their organic intelligence approach, combined with cutting-edge screening techniques, accelerates the identification of potential treatments and brings us closer to finding cures for rare diseases.
Generated from the website